跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FRAXIPARINE nadroparin calcium 5700IU anti-Xa/0.6mL - TGA Drug Approval Details
Approvals
/
TGA
/
FRAXIPARINE nadroparin calcium 5700IU anti-Xa/0.6mL
Approved
STANDARD
FRAXIPARINE nadroparin calcium 5700IU anti-Xa/0.6mL
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
50704fa9b24b42aa
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
50704fa9b24b42aa
Product Name
FRAXIPARINE nadroparin calcium 5700IU anti-Xa/0.6mL
Artg Id
51311
Artg Name
FRAXIPARINE nadroparin calcium 5700IU anti-Xa/0.6mL
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1995-09-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
50704fa9b24b42aa
Type
Standard
Back to TGA Approvals
